News

On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated ...
Iron sucrose injection is indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease.
Amphastar Pharmaceuticals (AMPH) upgraded to Buy by Needham after FDA approval for generic iron sucrose injection, marking ...
According to the FDA, Amphastar's iron sucrose injection meets the criteria for bioequivalence and therapeutic equivalence to ...
Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after a yearslong wait. | Generic ...
Viatris (VTRS) stock gains as the FDA OK its generic Iron Sucrose Injection targeting Venofer marketed by Daiichi Sankyo (DSKYF) (DSNKY) and Vifor. Read more here.
The FSSAI is proposing stricter sugar limits in baby food for children aged 6 to 24 months, amid rising obesity rates. The ...
A study on infant formulas reveals significant differences in sweetness, highlighting the impact of ingredients on children's ...
Venofer was approved in the U.S. in 2000. It was developed by Vifor Pharma, which is now part of CSL Ltd. American Regent, a unit of Daiichi Sankyo, manufactures and sells it in the U.S. under a ...
Breaks down the chemical properties of cotton versus sucrose, exploring why appearance can be deceiving in edible and ...